MX9203567A - MONOCOLIN DERIVATIVE, PROCEDURE FOR ITS PREPARATION AND MEDICATION CONTAINED IN THIS DERIVATIVE. - Google Patents
MONOCOLIN DERIVATIVE, PROCEDURE FOR ITS PREPARATION AND MEDICATION CONTAINED IN THIS DERIVATIVE.Info
- Publication number
- MX9203567A MX9203567A MX9203567A MX9203567A MX9203567A MX 9203567 A MX9203567 A MX 9203567A MX 9203567 A MX9203567 A MX 9203567A MX 9203567 A MX9203567 A MX 9203567A MX 9203567 A MX9203567 A MX 9203567A
- Authority
- MX
- Mexico
- Prior art keywords
- derivative
- hydrogen atom
- monocolin
- procedure
- preparation
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229930185711 monocolin Natural products 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- 241000228347 Monascus <ascomycete fungus> Species 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 230000010933 acylation Effects 0.000 abstract 1
- 238000005917 acylation reaction Methods 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Compounds of formula (I): <IMAGE> (in which R<1> and R<2>, which may be the same or different, each represents a hydrogen atom or an acyl group and R<3> represents a hydrogen atom or a methyl group, provided that, where R<1> represents a hydrogen atom, R<2> and R<3> cannot simultaneously be hydrogen atoms and R<2> cannot be a a- methylbutyryl group) inhibit the biosynthesis of cholesterol and hence can be used for the treatment of disorders resulting from high cholesterol levels. The compounds of the invention can be prepared by acylation of corresponding compounds where one or both of R<1> and R<2> represents a hydrogen atom and these may, in turn, be prepared by cultivation of microoorganisms of the genus Monascus.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP55041292A JPH0692381B2 (en) | 1980-03-31 | 1980-03-31 | MB-530A derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9203567A true MX9203567A (en) | 1992-09-01 |
Family
ID=12604367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9203567A MX9203567A (en) | 1980-03-31 | 1992-06-26 | MONOCOLIN DERIVATIVE, PROCEDURE FOR ITS PREPARATION AND MEDICATION CONTAINED IN THIS DERIVATIVE. |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPH0692381B2 (en) |
| AT (1) | ATA150781A (en) |
| AU (1) | AU6893281A (en) |
| BE (1) | BE888214A (en) |
| CH (1) | CH646966A5 (en) |
| DE (2) | DE3153666C2 (en) |
| DK (3) | DK151273C (en) |
| FI (1) | FI810991L (en) |
| FR (1) | FR2479222A1 (en) |
| GB (1) | GB2073193A (en) |
| IE (1) | IE52367B1 (en) |
| IT (1) | IT1144325B (en) |
| MX (1) | MX9203567A (en) |
| NL (1) | NL8101592A (en) |
| SE (1) | SE461590B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4472426A (en) * | 1982-12-22 | 1984-09-18 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| ATE69602T1 (en) * | 1985-09-13 | 1991-12-15 | Sankyo Co | HYDROXY-ML-236B DERIVATIVES, THEIR PREPARATION AND USE. |
| US4997848A (en) * | 1987-10-27 | 1991-03-05 | Sankyo Company, Limited | Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition |
| US5075327A (en) * | 1988-08-10 | 1991-12-24 | Hoffmann-La Roche Inc. | Antipsoriatic agents |
| US5021451A (en) * | 1988-11-14 | 1991-06-04 | Hoffman-La Roche Inc. | Method for inhibiting hyperproliferative diseases |
| US5200549A (en) * | 1988-11-14 | 1993-04-06 | Hoffman-La Roche Inc. | Antipsoriatic agents |
| US5073568A (en) * | 1988-11-14 | 1991-12-17 | Hoffmann-La Roche Inc. | Antipsoriatic agents |
| US5159104A (en) * | 1991-05-01 | 1992-10-27 | Merck & Co., Inc. | Process to simvastatin ester |
| FR2937537A1 (en) * | 2008-10-29 | 2010-04-30 | Centre Nat Rech Scient | NANOPARTICLES OF STATIN |
| KR101820099B1 (en) | 2013-01-18 | 2018-01-18 | 에스프린팅솔루션 주식회사 | resistive heat generating material, heating member and fusing device adopting the same |
| EP3737676B1 (en) | 2018-01-09 | 2024-03-06 | Ligand Pharmaceuticals, Inc. | Acetal compounds and therapeutic uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5612114B2 (en) * | 1974-06-07 | 1981-03-18 | ||
| JPS5925599B2 (en) * | 1979-02-20 | 1984-06-19 | 三共株式会社 | New physiologically active substance monacolin K and its production method |
| GR69216B (en) * | 1979-06-15 | 1982-05-07 | Merck & Co Inc | |
| US4231938A (en) * | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
| AU548996B2 (en) * | 1980-02-04 | 1986-01-09 | Merck & Co., Inc. | Tetrahydro-2h-pyran-2-one derivatives |
| PT72394B (en) * | 1980-02-04 | 1982-09-06 | Merck & Co Inc | Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics |
| ZA81703B (en) * | 1980-02-04 | 1982-09-29 | Merck & Co Inc | New antihypercholesterolemic compounds,intermediates and processes |
| US4282155A (en) * | 1980-02-04 | 1981-08-04 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
-
1980
- 1980-03-31 JP JP55041292A patent/JPH0692381B2/en not_active Expired - Lifetime
-
1981
- 1981-03-27 IE IE698/81A patent/IE52367B1/en not_active IP Right Cessation
- 1981-03-30 CH CH215381A patent/CH646966A5/en not_active IP Right Cessation
- 1981-03-30 DE DE3153666A patent/DE3153666C2/en not_active Expired - Lifetime
- 1981-03-30 DE DE19813112566 patent/DE3112566A1/en active Granted
- 1981-03-30 IT IT67438/81A patent/IT1144325B/en active
- 1981-03-31 GB GB8110075A patent/GB2073193A/en not_active Withdrawn
- 1981-03-31 AT AT0150781A patent/ATA150781A/en not_active IP Right Cessation
- 1981-03-31 FI FI810991A patent/FI810991L/en not_active Application Discontinuation
- 1981-03-31 DK DK145481A patent/DK151273C/en not_active IP Right Cessation
- 1981-03-31 AU AU68932/81A patent/AU6893281A/en not_active Abandoned
- 1981-03-31 BE BE0/204328A patent/BE888214A/en not_active IP Right Cessation
- 1981-03-31 SE SE8102047A patent/SE461590B/en not_active Application Discontinuation
- 1981-03-31 FR FR8106403A patent/FR2479222A1/en active Granted
- 1981-03-31 NL NL8101592A patent/NL8101592A/en not_active Application Discontinuation
-
1990
- 1990-02-07 DK DK032190A patent/DK167805B1/en not_active IP Right Cessation
- 1990-02-07 DK DK032290A patent/DK32290A/en not_active Application Discontinuation
-
1992
- 1992-06-26 MX MX9203567A patent/MX9203567A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL8101592A (en) | 1981-10-16 |
| SE461590B (en) | 1990-03-05 |
| DK32290D0 (en) | 1990-02-07 |
| JPS56138181A (en) | 1981-10-28 |
| IE52367B1 (en) | 1987-09-30 |
| DE3112566C2 (en) | 1990-04-05 |
| SE8102047L (en) | 1981-10-01 |
| AU6893281A (en) | 1981-10-08 |
| JPH0692381B2 (en) | 1994-11-16 |
| GB2073193A (en) | 1981-10-14 |
| DE3112566A1 (en) | 1982-03-11 |
| IT1144325B (en) | 1986-10-29 |
| IT8167438A0 (en) | 1981-03-30 |
| IE810698L (en) | 1981-09-30 |
| DK151273C (en) | 1988-07-04 |
| DE3153666C2 (en) | 1993-11-11 |
| BE888214A (en) | 1981-09-30 |
| DK32190A (en) | 1990-02-07 |
| FI810991L (en) | 1981-10-01 |
| DK32290A (en) | 1990-02-07 |
| DK151273B (en) | 1987-11-16 |
| DK32190D0 (en) | 1990-02-07 |
| DK145481A (en) | 1981-10-01 |
| FR2479222B1 (en) | 1983-08-26 |
| DK167805B1 (en) | 1993-12-20 |
| ATA150781A (en) | 1983-03-15 |
| FR2479222A1 (en) | 1981-10-02 |
| CH646966A5 (en) | 1984-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9204661A (en) | INTERMEDIATE COMPOUNDS DERIVED FROM ETER AND PROCEDURE FOR THE PREPARATION. | |
| BR8801410A (en) | PHOTOENDURECIVEL COMPOSITION | |
| NO912630L (en) | PROCEDURE FOR THE PREPARATION OF NEW 2,6-DIALKYL-4-SILYL-PHENOLES AS ANTI-AARTHERIOSCLEROTIC AGENTS | |
| GEP20022802B (en) | Steroid Sulphatase Inhibitors | |
| ES2074846T3 (en) | NEW NAFTIL-ETIL-UREAS AND NAFTIL-ETIL-TIOUREAS, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
| MX9301986A (en) | DERIVATIVES OF PERHYDROISOINDOL, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
| ES2046383T3 (en) | NEW DERIVATIVES OF DIPHOSPHONIC ACIDS, PROCEDURES FOR THEIR PREPARATION AND MEDICINES CONTAINING THESE COMPOUNDS. | |
| ES2104090T3 (en) | NEW 3 ', 5'-DI-T-BUTIL-4'-HIDROXI-FLAVONAS, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
| MX9203567A (en) | MONOCOLIN DERIVATIVE, PROCEDURE FOR ITS PREPARATION AND MEDICATION CONTAINED IN THIS DERIVATIVE. | |
| PT96381A (en) | A process for the preparation of 2-aminopyridineidine-4-carboxamide derivatives and pharmaceutical compositions containing them | |
| YU96291A (en) | PROCEDURE FOR OBTAINING SUBSTITUTED PIPERIDINES AND SUBSTITUTED PIPERIDINES | |
| IT9021645A0 (en) | PROCEDURE FOR THE TREATMENT OF REFINERY MATTER | |
| NZ228065A (en) | 1,2,4-triazinediones and parasiticidal compositions; processes for preparation | |
| ATE49957T1 (en) | ADAMANTANAMINE DERIVATIVES, METHOD OF PREPARATION AND MEDICATIONS CONTAINING THEM. | |
| ES2095068T3 (en) | POLYMERIC PEROXYCARBONATES AND PROCEDURE FOR PREPARING THEM. | |
| NO891703L (en) | PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PSORIASIS. | |
| FR2673625B1 (en) | NOVEL ACYLAMINOPHENOL DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| ATE134164T1 (en) | USE OF LYSOPHOSPHOLIPIDES AS SURFACEACTIVE AGENTS | |
| NO910559L (en) | PROCEDURE FOR THE PREPARATION OF POLYPHOSPHOSPHAS BY SUBSTITUTION OF THE POLYDICLORPHOSPHASE. | |
| DK439082A (en) | 4-ACYLAMINO-1-AZA-ADAMANTAN COMPOUNDS AND PROCEDURES FOR PREPARING THEREOF | |
| ES2078787T3 (en) | ARILIDEN-1-AZACICLOALCANOS AND ARILALQUIL-1-AZACICLOALCANOS, THEIR SALTS, MEDICINES CONTAINING THESE COMPOUNDS AND THEIR EMPLOYMENT, AS WELL AS THE PROCEDURE FOR THEIR PREPARATION. | |
| ES2074992T3 (en) | FUNGICIDE DERIVATIVES OF AZOLYL. | |
| FR2393798A1 (en) | TETRAHYDRO-1,3,5-THIADIAZINE-4-ONE DERIVATIVES FOR USE AS INSECTICIDE AND MITICIDE COMPOSITIONS | |
| IT7826768A0 (en) | PROCEDURE FOR THE ELIMINATION OF NITROSAMINES FROM DINITRO-ANILINES. | |
| ES2043072T3 (en) | PROCEDURE FOR THE DIACILATION OF COMPOUNDS THAT INCLUDE TWO AROMATIC NUCLEI. |